Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel (European Urology Oncology)

The size of an angiomyolipoma (AML) beyond which it needs to be treated remains unclear. Most small AMLs can be monitored without any active treatment. For those who need treatment, options include surgical removal or selective embolisation. Surgery has a lower recurrence rate and lower need for a repeat surgical procedure.